Queen Mary Hospital, the University of Hong Kong
Hong Kong
NCT Number: NCT06063720
This study prospectively evaluated the role of EWT versus SWT on adenoma detection rate (ADR) and other key quality metrics. In this prospective single-center study, patients undergoing colonoscopy were enrolled. EWT was calculated in real-time using an AI system with endoscopists blinded to the results. We performed multivariable analyses to assess the association of EWT and SWT with binary (e.g., ADR) and count outcomes (e.g., adenoma per colonoscopy [APC]), after adjusting for patient and procedural characteristics.
Looking for future studies?
Notify Me40 year and older
All sexes
Observational
Hong Kong
This was a prospective, single-center observational study designed to determine if an AI-powered metric, Effective Withdrawal Time (EWT), is a superior predictor of colonoscopy quality compared to the traditional Standard Withdrawal Time (SWT). All colonoscopies were performed by qualified endoscopists using high-definition white light video scopes. During the procedure, the scope is first advanced to the start of the large intestine (the cecum). The critical examination phase-the withdrawal-begins as the endoscopist slowly pulls the scope back out, meticulously inspecting the colon lining for abnormalities like polyps. It is during this withdrawal that the key metrics were measured. While SWT is a simple duration timed manually, the AI-measured EWT specifically quantifies the time of high-quality mucosal inspection, automatically excluding periods when the camera view is blurry, obscured, or moving too quickly. A crucial aspect of the methodology was that the endoscopists were blinded to the live EWT measurements to prevent the Hawthorne effect, where individuals alter their behaviour because they are being monitored. The study enrolled adults aged 40 and over, excluding patients with conditions that could confound the findings. The primary goal was to assess the independent impact of EWT on the Adenoma Detection Rate (ADR), a key benchmark based on the detection and removal of precancerous polyps for analysis. To achieve this, researchers used multivariable regression models to isolate EWT's effect from other variables and employed correlation tests to statistically compare whether EWT had a stronger relationship with detection quality than SWT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All adult patients, aged 40 or above, undergoing outpatient colonoscopy will be recruited
Exclusion criteria
Artificial intelligence monitoring of effective withdrawal time
Time frame: During the colonoscopy
Adenoma detection rates
Time frame: During that colonoscopy
Polyp detection rates of the colonoscopy
Time frame: During colonoscopy
Serrated lesion detection rates of that colonoscopy
Time frame: During colonoscopy
Advanced adenoma detection rates of that colonoscopy
Time frame: During colonoscopy
Adenoma per colonoscopy
Time frame: During colonoscopy
Polyp per colonoscopy
Time frame: During colonoscopy
Serrated lesion per colonoscopy
Time frame: During colonoscopy
Advanced adenoma per colonoscopy
The University of Hong Kong
Other
Prospective Evaluation of Artificial Intelligence-assisted Monitoring of Effective Withdrawal Time on Adenoma Detection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05784935
Artificial Intelligence, Colonic Polyp
Hyderabad, Telangana, India
View Trial DetailsNCT04440865
Artificial Intelligence, Colonic Adenoma
Charenton-le-Pont, France
View Trial DetailsNCT03949777
Colon Adenocarcinoma, Colon Adenoma
Tel Aviv, Israel
View Trial DetailsNCT04227795
Colon Adenoma, Colon Cancer
Hong Kong
View Trial Details